MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Comprehensive analysis of non-motor symptoms and their association with quality of life in writer’s cramp

    LY. Zhang, YB. Hou, J. Yang, B. Cao, HF. Shang (Chengdu, China)

    Objective: The current study aimed to examine the frequency of non-motor symptoms and their association with quality of life in patients with writer’s cramp. Background:…
  • MDS Virtual Congress 2021

    Implementing a Neuropalliative Care Curriculum for Neurology Residents Focused on Neurodegenerative Diseases

    O. Dubaz, J. Hauser (Boston, USA)

    Objective: To implement a neuropalliative care curriculum for neurology residents in order to increase comfort with palliative and hospice care topics for patients with progressive…
  • MDS Virtual Congress 2021

    Is the association between cigarette smoking and Parkinson disease causal? A Mendelian Randomization study.

    C. Domenighetti, PE. Sugier, A. Ashokkumar Sreelatha, C. Schulte, S. Grover, O. Mohamed, B. Portugal, P. May, D. Bobbili, M. Radivojkov-Blagojevic, P. Lichtner, R. Krüger, T. Gasser, M. Sharma, A. Elbaz (Villejuif Cedex, France)

    Objective: To determine whether the association between cigarette smoking and Parkinson disease (PD) is causal using 2-sample Mendelian randomization (MR) and to examine the potential…
  • MDS Virtual Congress 2021

    Body mass index and incidence of Parkinson’s disease in French women from the E3N cohort study

    B. Portugal, F. Artaud, C. Domenighetti, E. Roze, I. Dagaey, M. Canonico, A. Elbaz (Villejuif, France)

    Objective: We examined the association between BMI and PD incidence in women from the E3N cohort with repeated BMI measures over 29 years of follow-up,…
  • MDS Virtual Congress 2021

    Association between adverse childhood experiences and functional seizures among FND patients in the FND Patient Registry

    B. Mildon, E. Snow, J. Occean, N. Agu, A. Salinas-Miranda (Salmon, USA)

    Objective: This analysis examined the association between adverse childhood experiences (ACE) and functional seizures among FND patients. Background: Functional seizures are seizures of undetermined organic…
  • MDS Virtual Congress 2021

    Cumulative Real-World Experience with Deutetrabenazine for Huntington’s Disease Chorea at a Single Center of Excellence in the US

    K. Curtis, B. Denson, V. Sung (Birmingham, USA)

    Objective: To summarize clinical experience and outcomes with deutetrabenazine (DTBZ) as a treatment for Huntington’s disease (HD) chorea from the Huntington’s Disease Society of America…
  • MDS Virtual Congress 2021

    A screening tool to assess telehealth suitability among patients with Huntington’s disease

    S. Lee, L. Hale, K. Mcdonell (Nashville, USA)

    Objective: To evaluate a screening tool to assess telehealth (TH) suitability among Huntington’s disease (HD) patients Background: Extenuating patient circumstances [1] and COVID-19 necessitate greater…
  • MDS Virtual Congress 2021

    Visual cognition differences between asymptomatic and symptomatic carriers of Huntington’s disease (HD)

    M. Turuelo, MA. Acera, M. Diez-Cirarda, T. Fernández, B. Tijero, M. Carmona, M. Ruiz, J. Somme, J. Ruiz, A. Gabilondo, I. Croitoru, L. Pardina, N. Ayo, A. Murueta-Goyena, I. Gabilondo, JC. Gómez-Esteban, R. Del Pino (Barakaldo, Spain)

    Objective: This study aims to analyze the visual cognition profile of asymptomatic and symptomatic carriers of Huntington's disease (HD), compared with healthy controls (HC), and…
  • MDS Virtual Congress 2021

    Connectomic Analysis of SNc and VTA Projections to the Striatum and Cortex

    N. Handfield-Jones, A. Owen, A. Khan, P. Macdonald (London, Canada)

    Objective: To investigate the dopaminergic neural tracts of healthy individuals using Diffusion MRI on Human Connectome Project Data. Background: Classically, the DA system has been…
  • MDS Virtual Congress 2021

    A cell-penetrating peptide (CPP) did not decrease 150-kDa BoNT/A toxin adsorption to surfaces or increase toxin potency or duration in a prototype formulation

    D. Rupp, G. Nicholson, R. Briode, C. Nino, M. Do, J. Wan, L. Le, E. Vazquez-Cintron, C. Wu, M. Nelson, L. Steward, MF. Brin, A. Brideau-Andersen (Irvine, USA)

    Objective: To examine the effect of a cell-penetrating peptide (CPP) in a prototype formulation using toxin adsorption, in vivo potency, and duration analyses. Background: Unit…
  • « Previous Page
  • 1
  • …
  • 82
  • 83
  • 84
  • 85
  • 86
  • …
  • 132
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley